• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯胺酮通过抑制 HMGB1-RAGE 水平缓解 LPS 诱导的肺损伤。

Ketamine alleviates LPS induced lung injury by inhibiting HMGB1-RAGE level.

机构信息

Department of ICU, Affiliated Hospital of Weifang Medical College, Weifang, China.

出版信息

Eur Rev Med Pharmacol Sci. 2018 Mar;22(6):1830-1836. doi: 10.26355/eurrev_201803_14603.

DOI:10.26355/eurrev_201803_14603
PMID:29630133
Abstract

OBJECTIVE

Inflammatory cytokines secretion is an important reason to promote lung tissue inflammation in acute lung injury (ALI). High mobility group box 1 (HMGB-1) and its receptor for advanced glycation end products (RAGEs) play a role in ALI. Ketamine can significantly alleviate ALI, whereas its specific mechanism has not been fully elucidated.

MATERIALS AND METHODS

A total of 60 male Wistar rats were equally randomly divided into three groups, including ALI group which was established by 10 mg/kg LPS femoral vein injection, ketamine group which was constructed by 50 mg/kg ketamine femoral vein injection based on ALI model, and control group. Blood gas analysis was applied to detect arterial blood oxygen partial pressure (PaO2) and pH. Lung tissue wet/dry weight ratio (W/D), myeloperoxidase (MPO) and superoxide dismutase (SOD) activity were detected. Real-time PCR and ELISA were used to test HMGB-1 expression in lung tissue and serum. RAGE and NF-κB changes were determined by Real-time PCR and Western blot.

RESULTS

Compared with control, ALI group presented decreased PaO2 and PH, elevated W/D, enhanced MPO activity, declined SOD activity, upregulated HMGB-1 mRNA, increased HMGB-1 secretion, and increased RAGE and NF-κB mRNA and protein (p < 0.05). Ketamine treatment significantly elevated PaO2 and PH, reduced W/D, declined MPO activity, enhanced SOD activity, inhibited HMGB-1 mRNA and secretion, and downregulated RAGE and NF-κB mRNA and protein (p < 0.05).

CONCLUSIONS

Ketamine can alleviate LPS induced lung injury through inhibiting HMGB1-RAGE level. It could be treated as a new choice for ALI treatment.

摘要

目的

炎症细胞因子的分泌是促进急性肺损伤(ALI)肺组织炎症的一个重要原因。高迁移率族蛋白 B1(HMGB-1)及其晚期糖基化终产物受体(RAGEs)在 ALI 中起作用。氯胺酮能显著缓解 ALI,但具体机制尚未完全阐明。

材料与方法

雄性 Wistar 大鼠 60 只,随机分为三组,每组 20 只,包括脂多糖(LPS)10mg/kg 股静脉注射建立的 ALI 组、基于 ALI 模型 50mg/kg 氯胺酮股静脉注射的氯胺酮组和对照组。血气分析检测动脉血氧分压(PaO2)和 pH 值。检测肺组织湿/干重比(W/D)、髓过氧化物酶(MPO)和超氧化物歧化酶(SOD)活性。实时 PCR 和 ELISA 检测肺组织和血清中 HMGB-1 的表达。通过实时 PCR 和 Western blot 检测 RAGE 和 NF-κB 的变化。

结果

与对照组相比,ALI 组 PaO2 和 PH 值降低,W/D 升高,MPO 活性增强,SOD 活性降低,HMGB-1 mRNA 表达上调,HMGB-1 分泌增加,RAGE 和 NF-κB mRNA 和蛋白表达增加(p<0.05)。氯胺酮治疗后 PaO2 和 PH 值升高,W/D 降低,MPO 活性降低,SOD 活性升高,HMGB-1 mRNA 和分泌受抑制,RAGE 和 NF-κB mRNA 和蛋白表达下调(p<0.05)。

结论

氯胺酮通过抑制 HMGB1-RAGE 水平缓解 LPS 诱导的肺损伤,可作为 ALI 的治疗新选择。

相似文献

1
Ketamine alleviates LPS induced lung injury by inhibiting HMGB1-RAGE level.氯胺酮通过抑制 HMGB1-RAGE 水平缓解 LPS 诱导的肺损伤。
Eur Rev Med Pharmacol Sci. 2018 Mar;22(6):1830-1836. doi: 10.26355/eurrev_201803_14603.
2
Ketamine attenuates sepsis-induced acute lung injury via regulation of HMGB1-RAGE pathways.氯胺酮通过调节HMGB1-RAGE通路减轻脓毒症诱导的急性肺损伤。
Int Immunopharmacol. 2016 May;34:114-128. doi: 10.1016/j.intimp.2016.01.021. Epub 2016 Mar 2.
3
Ketamine alleviates HMGB1-induced acute lung injury through TLR4 signaling pathway.氯胺酮通过 TLR4 信号通路缓解高迁移率族蛋白 B1 诱导的急性肺损伤。
Adv Clin Exp Med. 2020 Jul;29(7):813-817. doi: 10.17219/acem/121936.
4
Ketamine delays progression of oxidative and damaged cataract through regulating HMGB-1/NF-κB in lens epithelial cells.氯胺酮通过调节晶状体上皮细胞中的 HMGB-1/NF-κB 延缓氧化损伤性白内障的进展。
Immunopharmacol Immunotoxicol. 2018 Aug;40(4):303-308. doi: 10.1080/08923973.2018.1478851. Epub 2018 Aug 15.
5
The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.右美托咪定通过 HMGB1 介导体 TLR4/NF-κB 和 PI3K/Akt/mTOR 通路对 LPS 诱导的急性肺损伤的保护作用。
Mol Immunol. 2018 Feb;94:7-17. doi: 10.1016/j.molimm.2017.12.008. Epub 2017 Dec 11.
6
Suppression of RAGE and TLR9 by Ketamine Contributes to Attenuation of Lipopolysaccharide-Induced Acute Lung Injury.氯胺酮对晚期糖基化终末产物受体(RAGE)和Toll样受体9(TLR9)的抑制作用有助于减轻脂多糖诱导的急性肺损伤。
J Invest Surg. 2017 Jun;30(3):177-186. doi: 10.1080/08941939.2016.1232448. Epub 2016 Oct 7.
7
[Role of HMGB1-RAGE/TLRs-NF-κB signaling pathway on bone mesenchymal stem cells transplantation therapy for lipopolysaccaride-induced coagulation disorder rats].HMGB1-RAGE/TLRs-NF-κB信号通路在脂多糖诱导的凝血功能障碍大鼠骨髓间充质干细胞移植治疗中的作用
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Sep;30(9):830-835. doi: 10.3760/cma.j.issn.2095-4352.2018.09.003.
8
Impact of ketamine intervention for acute lung injury on RAGE and TLR9.氯胺酮干预急性肺损伤对 RAGE 和 TLR9 的影响。
Eur Rev Med Pharmacol Sci. 2018 Jul;22(13):4350-4354. doi: 10.26355/eurrev_201807_15432.
9
Curcumin Attenuates Pulmonary Inflammation in Lipopolysaccharide Induced Acute Lung Injury in Neonatal Rat Model by Activating Peroxisome Proliferator-Activated Receptor γ (PPARγ) Pathway.姜黄素通过激活过氧化物酶体增殖物激活受体 γ(PPARγ)通路减轻脂多糖诱导的新生大鼠急性肺损伤的肺炎症。
Med Sci Monit. 2018 Feb 26;24:1178-1184. doi: 10.12659/msm.908714.
10
Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.乌司他丁治疗后可减轻脂多糖诱导的大鼠和人肺泡上皮细胞急性肺损伤。
Int J Mol Med. 2017 Feb;39(2):297-306. doi: 10.3892/ijmm.2016.2828. Epub 2016 Dec 13.

引用本文的文献

1
Esketamine mitigates endotoxin-induced acute lung injury by suppressing caspase-11-driven pyroptosis.艾氯胺酮通过抑制半胱天冬酶-11驱动的细胞焦亡减轻内毒素诱导的急性肺损伤。
BMC Anesthesiol. 2025 Jul 21;25(1):356. doi: 10.1186/s12871-025-03220-w.
2
Inflammation and coagulation abnormalities via the activation of the HMGB1‑RAGE/NF‑κB and F2/Rho pathways in lung injury induced by acute hypoxia.急性低氧诱导肺损伤中通过 HMGB1-RAGE/NF-κB 和 F2/Rho 通路的激活导致炎症和凝血异常。
Int J Mol Med. 2023 Aug;52(2). doi: 10.3892/ijmm.2023.5270. Epub 2023 Jun 23.
3
Therapeutic Potential of Targeting the HMGB1/RAGE Axis in Inflammatory Diseases.
靶向 HMGB1/RAGE 轴在炎症性疾病中的治疗潜力。
Molecules. 2022 Oct 27;27(21):7311. doi: 10.3390/molecules27217311.
4
Extracellular HMGB1 as Inflammatory Mediator in the Progression of Mycoplasma Gallisepticum Infection.细胞外 HMGB1 作为鸡毒支原体感染进展中的炎症介质。
Cells. 2022 Sep 9;11(18):2817. doi: 10.3390/cells11182817.
5
The Remarkable Roles of the Receptor for Advanced Glycation End Products (RAGE) and Its Soluble Isoforms in COVID-19: The Importance of RAGE Pathway in the Lung Injuries.晚期糖基化终末产物受体(RAGE)及其可溶性异构体在新型冠状病毒肺炎(COVID-19)中的显著作用:RAGE信号通路在肺损伤中的重要性
Indian J Clin Biochem. 2023 Apr;38(2):159-171. doi: 10.1007/s12291-022-01081-5. Epub 2022 Aug 18.
6
High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons.新冠病毒疾病中的高迁移率族蛋白B1(HMGB1):危险关联的推断
Inflammopharmacology. 2022 Jun;30(3):811-820. doi: 10.1007/s10787-022-00988-y. Epub 2022 Apr 26.
7
Upregulation of Matrix Metalloproteinase-9 Protects against Sepsis-Induced Acute Lung Injury via Promoting the Release of Soluble Receptor for Advanced Glycation End Products.基质金属蛋白酶-9 的上调通过促进晚期糖基化终产物可溶性受体的释放来保护脓毒症诱导的急性肺损伤。
Oxid Med Cell Longev. 2021 Feb 10;2021:8889313. doi: 10.1155/2021/8889313. eCollection 2021.
8
Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?细胞外 HMGB1:严重肺部炎症(包括 COVID-19)的治疗靶点?
Mol Med. 2020 May 7;26(1):42. doi: 10.1186/s10020-020-00172-4.
9
Anti-Inflammatory Effects of Shenfu Injection against Acute Lung Injury through Inhibiting HMGB1-NF-B Pathway in a Rat Model of Endotoxin Shock.参附注射液通过抑制内毒素休克大鼠模型中的HMGB1-NF-κB通路对急性肺损伤的抗炎作用
Evid Based Complement Alternat Med. 2019 Nov 3;2019:9857683. doi: 10.1155/2019/9857683. eCollection 2019.